Livanta Selects InterQual to Support its Medicare Utilization and Quality Care Reviews

NEWTON, Mass.--(BUSINESS WIRE)--Livanta has signed a long-term agreement to use InterQual® for utilization and quality reviews for Medicare beneficiaries, including short-stay inpatient status claims reviews. The healthcare services company licensed InterQual after becoming the Beneficiary and Family-Centered Care Quality Improvement Organization (BFCC-QIO) for Centers for Medicare & Medicaid Services (CMS) Areas 1 and 5. Specifically, Livanta has licensed InterQual Level of CareCare Planning Criteria and Behavioral Health Criteria.

Livanta is one of only two BFCC-QIOs charged by CMS to audit short-stay claims. Livanta serves its customers by advancing population health, improving patient care, and managing health care costs through quality improvement and innovation. It provides health information technology, healthcare consulting, program integrity, business process outsourcing, quality improvement, and strategic communications solutions to public sector and healthcare customers.

InterQual evidence-based criteria help improve clinical decision-making across the medical and behavioral health continuums of care. The InterQual clinical development team synthesizes the current, best evidence into a fully referenced decision support tool that is reviewed and updated annually. InterQual’s development process, honed over nearly 40 years, is founded on rigorous review of the literature, and includes extensive peer review by practicing clinical experts across the United States.

For more information on McKesson Health Solutions, please visit our website, hear from our experts at MHSdialogue, and follow us on Twitter at @McKesson_MHS.

Recent McKesson Health Solutions News

KEPRO Extends Use of InterQual® to Support Clinical Excellence in Utilization and Quality Reviews
McKesson InterQual® 2015 Sets New Standard for Peer-Reviewed Evidence-Based Clinical Content
Over 600 Payers, Providers Chose McKesson InterQual® Criteria for Clinical Decision Support

About McKesson Corporation
McKesson Corporation, currently ranked 11th on the FORTUNE 500, is a healthcare services and information technology company dedicated to making the business of healthcare run better. McKesson partners with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care to build healthier organizations that deliver better care to patients in every setting. McKesson helps its customers improve their financial, operational, and clinical performance with solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services. For more information, visit www.mckesson.com.

Contacts

McKesson Health Solutions
Amy Valli, 215-962-5531
Public Relations
amy.valli@mckesson.com

 

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”